Company profile
IMRIS Inc.
OTC: IMRSQ · Healthcare · Medical - Devices
Canadian filerReports USD
#508 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ —GM —SS 26
v0.1 · 5/100 weight · pillars only
↑ workforce scale, growth stability · ↓ market scale, listing tenure
Methodology →Revenue TTM
$28.9M
Rev growth YoY (TTM)
-37.3%
Net income (FY)
-$30.4M
Employees
121
as of 2026-08-31
Market cap
$626
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$28.9M$28.9M2014
Net income-$30.4M-$30.4M2014
Operating income-$23.1M-$23.1M2014
Total assets$65.5M$65.5M2014
Liabilities$53.7M$53.7M2014
Equity$11.8M$11.8M2014
Revenue trend
FY2007 – FY2014 · USD
FY07
FY08
FY09
FY10
FY11
FY12
FY13
FY14
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is IMRIS Inc.’s revenue?
IMRIS Inc. booked $28.9M in FY2014 revenue, contracting 37% year over year — slower than 78% of Healthcare companies we track, at a -105.2% net margin.
Peers · Healthcare
Synergy CHC Corp.35DScilex Holding Company28DDelota Corp.——Nanalysis Scientific Corp.59COscar Health, Inc.50DBionano Genomics, Inc.48DKey facts
CEOMarc Buntaine
SectorHealthcare
IndustryMedical - Devices
Headquarters—
ExchangeOTC: IMRSQ
Employees121
IPO date2023-01-20
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.